Pediatric bone and joint infections caused by Panton-Valentine leukocidin-positive Staphylococcus aureus

Author(s): Dohin B, Gillet Y, Kohler R, Lina G, Vandenesch F, et al.


Background:Panton-Valentine leukocidin (PVL) is a necrotizing toxin secreted by Staphylococcus aureus. PVL-positive S. aureus osteomyelitis and arthritis have been described.

Methods:We analyzed demographic, clinical, laboratory, microbiologic, and imaging data in a study group of 14 pediatric cases with PVL-positive S. aureus osteomyelitis and arthritis diagnosed between 2001 and 2005 and compared results with a control group of 17 pediatric cases of PVL-negative S. aureus osteomyelitis and arthritis treated in our institution during the same period. Treatments and outcome were studied.

Results:The severity of PVL-positive S. aureus bone and joint infections was indicated by the presence of severe sepsis in all cases and of septic shock in 6 of the 14 patients. By comparison, severe sepsis was not noted in the control group (P = 0.004). On admission, the median C-reactive protein value was significantly higher in the study group (202.6 mg/L versus 83 mg/L in the control group; P = 0.001). Eleven patients with PVL-positive infection had local extension of the infection by magnetic resonance imaging and 7 patients had severe deep-seated infectious complications by computed tomography. By contrast only 1 patient in the control group presented with bone abscess without extension and none had deep-seated infection (P < 0.001). The median length of hospitalization was 45.5 days in the study group versus 13 days in the control group (P < 0.001). The median duration of intravenous antibacterial chemotherapy was 48 days versus 11.3 days in the control group (P < 0.001). Ten patients (71%) of the study group required surgical procedures with a mean of 3 procedures (range, 1-5) whereas 3 patients (17%) of the control group required 1 surgical drainage each (P = 0.002). All the patients survived, but only 2 patients of the study group were free of long-term complications, whereas there were no long-term complications noted in the control group.

Conclusion:PVL-positive S. aureus bone and joint infection is severe and requires prolonged treatment. Local complications are more frequent and often need repeated surgical drainage.

Similar Articles

Does this adult patient have septic arthritis? JAMA 297: 1478-1488

Author(s): Margaretten ME, Kohlwes J, Moore D, Bent S

Risk factors for septic arthritis in patients with joint disease

Author(s): Kaandorp CJ, Van Schaardenburg D, Krijnen P, Habbema JD, van de Laar MA

Incidence and sources of native and prosthetic joint infection: a community based prospective survey

Author(s): Kaandorp CJ, Dinant HJ, van de Laar MA, Moens HJ, Prins AP, et al.

Septic arthritis of the hip associated with atopic dermatitis

Author(s): Kitamura S, Nakayama Y, Shirai Y, Hashiguchi H, Kim R

Pay attention to valvular disease in the presence of atopic dermatitis

Author(s): Fukunaga N, Okada Y, Konishi Y, Murashita T, Koyama T

Increasing incidence of streptococcal impetigo in atopic dermatitis

Author(s): Adachi J, Endo K, Fukuzumi T, Tanigawa N, Aoki T